Development and reporting of artificial intelligence in osteoporosis management.

IF 5.1 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Guillaume Gatineau, Enisa Shevroja, Colin Vendrami, Elena Gonzalez Rodriguez, William D Leslie, Olivier Lamy, Didier Hans
{"title":"Development and reporting of artificial intelligence in osteoporosis management.","authors":"Guillaume Gatineau, Enisa Shevroja, Colin Vendrami, Elena Gonzalez Rodriguez, William D Leslie, Olivier Lamy, Didier Hans","doi":"10.1093/jbmr/zjae131","DOIUrl":null,"url":null,"abstract":"<p><p>An abundance of medical data and enhanced computational power have led to a surge in Artificial Intelligence (AI) applications. Published studies involving AI in bone and osteoporosis research have increased exponentially, raising the need for transparent model development and reporting strategies. This review offers a comprehensive overview and systematic quality assessment of AI articles in osteoporosis while highlighting recent advancements. A systematic search in the PubMed database, from December 17th, 2020, to February 1st, 2023 was conducted to identify AI articles that relate to osteoporosis. The quality assessment of the studies relied on the systematic evaluation of 12 quality items derived from the MI-CLAIM checklist. The systematic search yielded 97 articles that fell into five areas; bone properties assessment (11 articles), osteoporosis classification (26 articles), fracture detection/classification (25 articles), risk prediction (24 articles) and bone segmentation (11 articles). The average quality score for each study area was 8.9 (range: 7-11) for bone properties assessment, 7.8 (range: 5-11) for osteoporosis classification, 8.4 (range: 7-11) for fracture detection, 7.6 (range: 4-11) for risk prediction, and 9.0 (range: 6-11) for bone segmentation. A 6th area, AI-driven clinical decision support, identified the studies from the five preceding areas which aimed to improve clinician efficiency, diagnostic accuracy and patient outcomes through AI-driven models and opportunistic screening by automating or assisting with specific clinical tasks in complex scenarios. The current work highlights disparities in study quality and a lack of standardized reporting practices. Despite these limitations, a wide range of models and examination strategies have shown promising outcomes to aid in the earlier diagnosis and improve clinical decision making. Through careful consideration of sources of bias in model performance assessment, the field can build confidence in AI-based approaches, ultimately leading to improved clinical workflows and patient outcomes.</p>","PeriodicalId":185,"journal":{"name":"Journal of Bone and Mineral Research","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone and Mineral Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jbmr/zjae131","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

An abundance of medical data and enhanced computational power have led to a surge in Artificial Intelligence (AI) applications. Published studies involving AI in bone and osteoporosis research have increased exponentially, raising the need for transparent model development and reporting strategies. This review offers a comprehensive overview and systematic quality assessment of AI articles in osteoporosis while highlighting recent advancements. A systematic search in the PubMed database, from December 17th, 2020, to February 1st, 2023 was conducted to identify AI articles that relate to osteoporosis. The quality assessment of the studies relied on the systematic evaluation of 12 quality items derived from the MI-CLAIM checklist. The systematic search yielded 97 articles that fell into five areas; bone properties assessment (11 articles), osteoporosis classification (26 articles), fracture detection/classification (25 articles), risk prediction (24 articles) and bone segmentation (11 articles). The average quality score for each study area was 8.9 (range: 7-11) for bone properties assessment, 7.8 (range: 5-11) for osteoporosis classification, 8.4 (range: 7-11) for fracture detection, 7.6 (range: 4-11) for risk prediction, and 9.0 (range: 6-11) for bone segmentation. A 6th area, AI-driven clinical decision support, identified the studies from the five preceding areas which aimed to improve clinician efficiency, diagnostic accuracy and patient outcomes through AI-driven models and opportunistic screening by automating or assisting with specific clinical tasks in complex scenarios. The current work highlights disparities in study quality and a lack of standardized reporting practices. Despite these limitations, a wide range of models and examination strategies have shown promising outcomes to aid in the earlier diagnosis and improve clinical decision making. Through careful consideration of sources of bias in model performance assessment, the field can build confidence in AI-based approaches, ultimately leading to improved clinical workflows and patient outcomes.

骨质疏松症管理中人工智能的开发和报告。
医疗数据的丰富和计算能力的增强导致了人工智能(AI)应用的激增。已发表的涉及人工智能在骨骼和骨质疏松症研究中的应用的研究呈指数级增长,这就提出了对透明的模型开发和报告策略的需求。本综述对骨质疏松症方面的人工智能文章进行了全面的概述和系统的质量评估,同时强调了最近的进展。从 2020 年 12 月 17 日到 2023 年 2 月 1 日,我们在 PubMed 数据库中进行了系统检索,以确定与骨质疏松症有关的人工智能文章。对研究质量的评估依赖于对来自 MI-CLAIM 检查表的 12 个质量项目的系统评估。系统性搜索共获得 97 篇文章,分为五个领域:骨特性评估(11 篇)、骨质疏松症分类(26 篇)、骨折检测/分类(25 篇)、风险预测(24 篇)和骨分割(11 篇)。每个研究领域的平均质量得分分别为:骨特性评估 8.9 分(范围:7-11),骨质疏松症分类 7.8 分(范围:5-11),骨折检测 8.4 分(范围:7-11),风险预测 7.6 分(范围:4-11),骨分割 9.0 分(范围:6-11)。第六个领域是人工智能驱动的临床决策支持,该领域确定了前五个领域中的研究,旨在通过人工智能驱动的模型和机会性筛查,在复杂场景中自动完成或协助完成特定临床任务,从而提高临床医生的效率、诊断准确性和患者预后。目前的研究工作凸显了研究质量的差异和缺乏标准化报告实践的问题。尽管存在这些局限性,但各种模型和检查策略在帮助早期诊断和改善临床决策方面都取得了可喜的成果。通过仔细考虑模型性能评估中的偏差来源,该领域可以建立对基于人工智能方法的信心,最终改善临床工作流程和患者预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Bone and Mineral Research
Journal of Bone and Mineral Research 医学-内分泌学与代谢
CiteScore
11.30
自引率
6.50%
发文量
257
审稿时长
2 months
期刊介绍: The Journal of Bone and Mineral Research (JBMR) publishes highly impactful original manuscripts, reviews, and special articles on basic, translational and clinical investigations relevant to the musculoskeletal system and mineral metabolism. Specifically, the journal is interested in original research on the biology and physiology of skeletal tissues, interdisciplinary research spanning the musculoskeletal and other systems, including but not limited to immunology, hematology, energy metabolism, cancer biology, and neurology, and systems biology topics using large scale “-omics” approaches. The journal welcomes clinical research on the pathophysiology, treatment and prevention of osteoporosis and fractures, as well as sarcopenia, disorders of bone and mineral metabolism, and rare or genetically determined bone diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信